A review of hte the aquabeam robotic system's log file was conducted, which confirmed no malfunctions were observed during the aquablation procedure.The review of the log file indicated that the system functioned as designed.A review of the device history record (dhr) for serial number (b)(6) was conducted, which confirmed that there were no nonconformances generated during the manufacturing process of this system.The review indicated that the system met all required specifications upon release for distribution.A review for similar complaints was performed on serial number (b)(6), which confirmed that there were no other similar events reported on this system.A review for similar events across all systems confirmed no other similar events.The aquabeam robotic system's instructions for use (ifu), ifu0101-00, rev.D, was reviewed and states the following: 3.Contraindications: do not use the aquabeam robotic system in patients who do not meet the indication for the system's intended use.4.3.Warnings: procedure: as with any surgical urologic procedure, potential perioperative risks of the aquablation procedure include: o bleeding.A root cause for the reported event could not be determined.The patient was transfused 26 days post-aquablation procedure; however, the bleeding is unlikely related to the procedure.No further information could be gathered from the treating physician.Based on the review of the log file, dhr, and ifu, the reported event is considered to be not device related.Submission of this report does not constitute an admission that the manufacturer's product caused or contributed to the event.
|